News

AddToAny

Google+ Facebook Twitter Twitter

Harvey's gang charity lab tour

Jill Rodney, the IBMS Chief Executive, took part in a charity laboratory tour at St Richard’s Hospital in Chichester. 

Jill Rodney, the IBMS Chief Executive, took part in a charity laboratory tour at St Richard’s Hospital in Chichester. 

She joined Harvey’s Gang founder and IBMS member Malcolm Robinson and five-year-old patient Zofia, who was accompanied by her father Jacek, on a blood transfusion laboratory tour.

Harvey’s Gang is a charity initiative that invites youngsters with cancer and other serious illnesses to become trainee biomedical scientists for the day and tour pathology laboratories with their families.

Both Jill and Zofia were given special Harvey’s Gang lab coats for their tour, with Zofia wearing hers all day at school after the tour.

Jill said: “It was amazing to see first-hand the work that Malcolm and his team are undertaking here. 

“To see the joy on Zofia’s face as she was shown around the lab was wonderful. The Harvey’s Gang initiative is truly inspiring and I am thankful to Malcolm for inviting me, as well as to Zofia and her Dad for allowing me to join her on her tour.” 

For info, to make a donation, or to get involved, visit harveysgang.blogspot.co.uk

Related Articles

Transfusion: training hub

Jill Caulfield, Transfusion 2024 Education Development Lead at NHS Blood and Transplant, introduces a “one-stop shop” of training resources.

VR-headset - CREDIT -getty

Improving transfusion with training

Ruth Evans and Laura Eastwood from NHS Blood and Transplant discuss virtual reality training for blood transfusion testing.

red blood cells CREDIT-iStock-1227353965

Casestudy acquired protein s deficiency

Healthcare Science Section Lead in Haematology and Haemostasis Michelle Bolam presents a case study in which a two-year-old presented with an unprovoked extensive deep vein thrombosis.

paper cuts - CREDIT - Richard-Gleed

DNA: Cutting the future of genome editing

The latest CRISPR-Cas technology has been used to eliminate all traces of HIV from infected cells in the lab. Here we look at how gene editing could revolutionise clinical treatments and ask what the limitations are for its future use.

Top